Vivani Medical CFO Anthony Baldor Receives Equity Awards

What Happened

• Anthony Baldor, Chief Financial Officer of Vivani Medical (VANI), was granted equity awards on July 28, 2026. The filing shows two derivative awards: 75,000 shares in the form of stock options and 37,500 restricted stock units (RSUs). Both grants were reported with a $0.00 acquisition price, meaning no cash was paid by Baldor to receive these awards.

Key Details

• Transaction date: 2026-07-28; Form 4 filed 2026-07-30 (appears timely).
• Grant details: 75,000 stock options; 37,500 RSUs. Both reported as award/acquisition (code A, derivative).
• Price/value shown: $0.00 per share (no cash paid at grant).
• Shares owned after transaction: Not disclosed in the filing.
• Footnotes/vesting:
  • Options (Footnote F1): 10-year term; vest 25% after one year, then monthly vesting over the next 36 months, subject to continued service.
  • RSUs (Footnote F2): Each RSU represents a contingent right to receive one share of common stock.
  • Performance RSUs (Footnote F3): Vest in three stages tied to a market condition — one-third vests when the stock is at or above $3.15 for three consecutive trading days; the next two thirds vest one year apart after that milestone is first achieved. If the $3.15 condition is not met within four years, those RSUs expire.
• Exhibit noted: Exhibit 24 — Power of Attorney.

Context

• These are compensation awards (not open-market purchases or sales) and therefore reflect company compensation decisions rather than an insider buying or selling shares. The stock options provide the right to buy shares in the future (subject to vesting and their 10-year term); RSUs convert to shares if/when vested. The performance RSUs include a specific market-price condition ($3.15) and can expire if that condition isn’t met within the stated period.